References
- Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139:137–147
- Borges A, Borges M, Fernandes J, et al. Apoptosis of peripheral CD4 (+) T-lymphocytes in end-stage renal disease patients under hemodialysis and rhEPO therapies. Ren Fail. 2011;33(2):138–143
- Szczepánska M, Szprynger K, Mazur B, Szczepánski T. Alpha beta and gamma delta T cell subsets in chronic renal failure in children on dialysis treatment. Pediatr Int. 2002;44(1):32–36
- Pahl MV, Gollapudi S, Sepassi L, Gollapudi P, Elahimehr R, Vaziri ND. Effect of end-stage renal disease on B-lymphocyte subpopulation, IL-7, BAFF and BAFF receptor expression. Nephrol Dial Transplant. 2010;25(1):205–212
- Vaziri ND, Pahl MV, Crum A, Norris K. Effect of uremia on structure and function of immune system. J Ren Nutr. 2012;22(1):149–156
- Girndt M, Sester U, Sester M, Kaul H, Kohler H. Impaired cellular immune function in patients with end-stage renal failure. Nephrol Dial Transplant. 1999;14:2807–2810
- Pereira BJ, Shapiro L, King AJ, Falagas ME, Strom JA, Dinarello CA. Plasma levels of IL-1 beta, TNF alpha and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients. Kidney Int. 1994;45:890–896
- Zwolinska D, Medynska A, Szprynger K, Szczepanska M. Serum concentration of IL-2, IL-6, TNF-alpha and their soluble receptors in children on maintenance hemodialysis. Nephron. 2000;86:441–446
- Nairn J, Hodge G, Henning P. Changes in leukocyte subsets: clinical implications for children with chronic renal failure. Pediatr Nephrol. 2005;20:190–196
- Bouts AH, Out TA, Schroder CH, et al. Characteristics of peripheral and peritoneal white blood cells in children with chronic renal failure dialyzed or not. Perit Dial Int. 2000;20:748–756
- Moser B, Roth G, Brunner M, et al. Aberrant T cell activation and heightened apoptotic turnover in end-stage renal failure patients: a comparative evaluation between non-dialysis, hemodialysis, and peritoneal dialysis. Biochem Biophys Res Commun. 2003;308:581–585
- Matsumoto Y, Shinzato T, Amano I, et al. Relationship between susceptibility to apoptosis and Fas expression in peripheral blood T cells from uremic patients: a possible mechanism for lymphopenia in chronic renal failure. Biochem Biophys Res Commun. 1995;215:98–105
- Meier P, Dayer E, Blanc E, Wauters JP. Early T cell activation correlates with expression of apoptosis markers in patients with end-stage renal disease. J Am Soc Nephrol. 2002;13:204–212
- Kipps T. The CD5 B cell. Adv Immunol. 1989;47:117–185
- Herzenberg L, Haughton G, Rajewsky K. CD5 B cells in development and disease. Ann NY Acad Sci. 1992;651:591–601
- Martin F, Kearney JF. B1 cells: similarities and differences with other B cell subsets. Curr Opin Immunol. 2001;13:195–201
- Uckun F. Regulation of human B-cell ontogeny. Blood. 1990;76:1908–1923
- Gray D. Immunological memory: a function of antigen persistence. Trends Microbiol. 1993;1:39–41
- Bouts AH, Davin JC, Krediet RT, et al. Children with chronic renal failure have reduced numbers of memory B cells. Clin Exp Immunol. 2004;137(3):589–594
- Fernandez-Fresnedo G, Ramos MA, Gonzalez-Pardo MC, de Francisco AL, Lopez-Hoyos M, Arias M. B lymphopenia in uremia is related to an accelerated in vitro apoptosis and dysregulation of Bcl-2. Nephrol Dial Transplant. 2000;15:502–510